These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

746 related items for PubMed ID: 9707042

  • 1. One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: a randomized, clinical trial.
    van der Wouden EJ, Thijs JC, van Zwet AA, Kooy A, Kleibeuker JH.
    Am J Gastroenterol; 1998 Aug; 93(8):1228-31. PubMed ID: 9707042
    [Abstract] [Full Text] [Related]

  • 2. Reduced symptoms and need for antisecretory therapy in veterans 3 years after Helicobacter pylori eradication with ranitidine bismuth citrate/amoxicillin/clarithromycin.
    Sontag SJ, O'Connell S, Schnell T, Chejfec G, Seidel J, Sonnenberg A.
    Am J Gastroenterol; 2001 May; 96(5):1390-5. PubMed ID: 11374672
    [Abstract] [Full Text] [Related]

  • 3. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
    Laine L, Estrada R, Trujillo M, Emami S.
    Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
    [Abstract] [Full Text] [Related]

  • 4. Optimal treatment of Helicobacter pylori with ranitidine bismuth citrate (RBC): a randomized comparison between two 7-day triple therapies and a 14-day dual therapy.
    de Boer WA, Haeck PW, Otten MH, Mulder CJ.
    Am J Gastroenterol; 1998 Jul; 93(7):1101-7. PubMed ID: 9672338
    [Abstract] [Full Text] [Related]

  • 5. Ranitidine bismuth citrate with clarithromycin given twice daily effectively eradicates Helicobacter pylori and heals duodenal ulcers.
    Bardhan KD, Wurzer H, Marcelino M, Jahnsen J, Lotay N, Roberts PM.
    Am J Gastroenterol; 1998 Mar; 93(3):380-5. PubMed ID: 9517644
    [Abstract] [Full Text] [Related]

  • 6. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
    Köksal AS, Parlak E, Filik L, Yolcu OF, Odemiş B, Ulker A, Saşmaz N, Ozden A, Sahin B.
    J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
    [Abstract] [Full Text] [Related]

  • 7. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
    Kung NN, Sung JJ, Yuen NW, Li TH, Ng PW, Lai WM, Lui YH, Lam KN, Choi CH, Leung EM.
    Am J Gastroenterol; 1999 Mar; 94(3):721-4. PubMed ID: 10086657
    [Abstract] [Full Text] [Related]

  • 8. [Lansoprazole versus ranitidine bismuth citrate containing triple regimens for Helicobacter pylori eradication in patients with duodenal ulcer].
    Buzás György M, Székely E, Illyés G, Széles I.
    Orv Hetil; 2000 Jul 30; 141(31):1711-4. PubMed ID: 10976194
    [Abstract] [Full Text] [Related]

  • 9. The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.
    Bago J, Halle ZB, Strinić D, Kućisec N, Jandrić D, Bevanda M, Tomić M, Bilić A.
    Wien Klin Wochenschr; 2002 Jun 28; 114(12):448-53. PubMed ID: 12422579
    [Abstract] [Full Text] [Related]

  • 10. Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (metronidazole for eradication, ranitidine for pain).
    Tefera S, Berstad A, Bang CJ, Nysaeter G, Hatlebakk JG, Olafsson S, Nesje LB, Hausken T, Berstad K, Hundal O.
    Am J Gastroenterol; 1996 May 28; 91(5):935-41. PubMed ID: 8633584
    [Abstract] [Full Text] [Related]

  • 11. Effectiveness of ranitidine bismuth citrate based triple therapy for treating Helicobacter pylori.
    Thong-Ngam D, Tangkijvanich P, Treeprasertsuk S, Wisedopas N, Kullavanijaya P.
    J Med Assoc Thai; 2002 Oct 28; 85(10):1054-9. PubMed ID: 12501895
    [Abstract] [Full Text] [Related]

  • 12. Duodenal ulcer healing rates in a one-year follow-up study with ranitidine bismuth citrate and antibiotics.
    Wurzer H, Bardhan KD, Marcelino M, Jahnsen J, Allmaier M.
    Hepatogastroenterology; 2001 Oct 28; 48(42):1641-7. PubMed ID: 11813591
    [Abstract] [Full Text] [Related]

  • 13. Ten-day triple therapy with ranitidine bismuth citrate, amoxicillin, and clarithromycin in eradicating Helicobacter pylori.
    Vakil N, Cutler A.
    Am J Gastroenterol; 1999 May 28; 94(5):1197-9. PubMed ID: 10235192
    [Abstract] [Full Text] [Related]

  • 14. Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial.
    Chey WD, Fisher L, Elta GH, Barnett JL, Nostrant T, DelValle J, Hasler WL, Scheiman JM.
    Am J Gastroenterol; 1997 Sep 28; 92(9):1483-6. PubMed ID: 9317068
    [Abstract] [Full Text] [Related]

  • 15. A comparison between omeprazole-based triple therapy and bismuth-based triple therapy for the treatment of Helicobacter pylori infection: a prospective randomized 1-yr follow-up study.
    Lerang F, Moum B, Ragnhildstveit E, Haug JB, Hauge T, Tolås P, Aubert E, Henriksen M, Efskind PS, Nicolaysen K, Søberg T, Odegaard A, Berge T.
    Am J Gastroenterol; 1997 Apr 28; 92(4):653-8. PubMed ID: 9128317
    [Abstract] [Full Text] [Related]

  • 16. Ranitidine bismuth citrate with clarithromycin alone or with metronidazole for the eradication of Helicobacter pylori.
    Bardhan KD, Morton D, Perry MJ, Sanders DS, Morris P, Rowland A, Thompson M, Mitchell TR, Roberts PM.
    Aliment Pharmacol Ther; 2001 Aug 28; 15(8):1199-204. PubMed ID: 11472323
    [Abstract] [Full Text] [Related]

  • 17. Effectiveness of ranitidine bismuth citrate, clarithromycin, and metronidazole therapy for treating Helicobacter pylori.
    Smoot DT, Hinds T, Ashktorab H, Jagtap J, Kim KS, Scott VF.
    Am J Gastroenterol; 1999 Apr 28; 94(4):955-8. PubMed ID: 10201463
    [Abstract] [Full Text] [Related]

  • 18. 7-day rescue therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failure.
    Gisbert JP, Fuentes J, Carpio D, Tito L, Guardiola J, Tomas A, Olivares D, Calvet X.
    Aliment Pharmacol Ther; 2005 May 15; 21(10):1249-53. PubMed ID: 15882246
    [Abstract] [Full Text] [Related]

  • 19. The efficacy of two-week therapy with ranitidine bismuth citrate, amoxicillin and clarithromycin on Helicobacter pylori eradication in clarithromycinresistant and- sensitive cases.
    Aydin A, Onder GF, Akarca US, Tekin F, Tunçyürek M, Musoğlu A.
    Turk J Gastroenterol; 2005 Dec 15; 16(4):203-6. PubMed ID: 16547848
    [Abstract] [Full Text] [Related]

  • 20. Seven-day is more effective than 4-day ranitidine bismuth citrate-based triple therapy in eradication of Helicobacter pylori in children: a prospective randomized study.
    Tam YH, Yeung CK, Lee KH.
    Aliment Pharmacol Ther; 2006 Jul 01; 24(1):81-6. PubMed ID: 16803605
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.